To create insight and awareness in the Netherlands, we compared ER-, PR- and HER2-receptor positivity rates from daily clinical practice between pathology laboratories using real-life data from synoptic (structured) pathology reports of 33,046 IBC patients from the Dutch nationwide pathology registry (PALGA). The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.